Atrial fibrillation combined acute coronary syndrome
Conditions
Interventions
None listed
Sponsors
Juntendo University Department of Cardiovascular Medicine, Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with ACS meeting following criteria who are admitted to hospitals will be enrolled in this registry, if patients are confirmed to have atrial fibrillation until discharge and provide written informedconsent. Patients will be consecutively registered at study sites.
Exclusion criteria
Exclusion criteria: 1) ACS caused by surgery, trauma, or coronary rebascularization (PCI or CABG) 2) Patients under 20years of age 3) Transient af after the onset of ACS is excluded 4) Patients considered inappropriatc for study participation by attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| #1 Major Bleeding according to International Soiety of Thrombosis and Hemostasis (ISTH) #2 MACCE (major adverse cardio-cerebral event): composite endpoint of death associated withACS/storoke and other cardiovascular (CV) deaths, non-fatal ACS and non-fatal stroke,and stent thrombosis | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Death due to hemorrhage, 2) Cardiac death, CV death (cause of mortality) 3) Non-CV death (cause of death;final clinical diagnosis of death) 4) Bleeding | — |
Countries
Japan
Contacts
Public ContactKatumi Miyauchi
Juntendo University Department of Cardiovascular Medicine, Graduate School of Medicine
Outcome results
None listed